128 related articles for article (PubMed ID: 3059767)
21. Biochemical characterization of regulatory factors derived from T cell hybridomas and spleen cells. II. Evidence for glycosylation of T cell growth factor, T cell replacing factor, and granulocyte-macrophage colony-stimulating factor.
Clark-Lewis I; Schrader JW
J Immunol; 1982 Jan; 128(1):175-80. PubMed ID: 6976370
[TBL] [Abstract][Full Text] [Related]
22. Generation of human hybridomas producing migration inhibitory factor (MIF) and of murine hybridomas secreting monoclonal antibodies to human MIF.
Weiser WY; Remold HG; David JR
Cell Immunol; 1985 Jan; 90(1):167-78. PubMed ID: 3881187
[TBL] [Abstract][Full Text] [Related]
23. Th2 lymphocyte clone can activate macrophage antileishmanial defense by a lymphokine-independent mechanism in vitro and can augment parasite attrition in vivo.
Sypek JP; Matzilevich MM; Wyler DJ
Cell Immunol; 1991 Mar; 133(1):178-86. PubMed ID: 1825032
[TBL] [Abstract][Full Text] [Related]
24. Human recombinant migration inhibitory factor activates human macrophages to kill Leishmania donovani.
Weiser WY; Pozzi LM; David JR
J Immunol; 1991 Sep; 147(6):2006-11. PubMed ID: 1909737
[TBL] [Abstract][Full Text] [Related]
25. Macrophage-activating factor for cytotoxicity produced by a human T-cell hybridoma.
Higuchi M; Nakamura N; Tsuchiya SI; Kobayashi Y; Osawa T
Cell Immunol; 1984 Sep; 87(2):626-36. PubMed ID: 6205774
[TBL] [Abstract][Full Text] [Related]
26. Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.
Murray HW; Rubin BY; Rothermel CD
J Clin Invest; 1983 Oct; 72(4):1506-10. PubMed ID: 6415111
[TBL] [Abstract][Full Text] [Related]
27. Functional identity between murine gamma interferon and macrophage activating factor.
Schultz RM; Kleinschmidt WJ
Nature; 1983 Sep 15-21; 305(5931):239-40. PubMed ID: 6412144
[TBL] [Abstract][Full Text] [Related]
28. Partial purification of a macrophage-activating factor for glucose consumption (MAF-G) produced by a human T-cell hybridoma and its relation to a growth-promoting factor.
Osada H; Furukawa-Nakanishi K; Miyamoto D; Kobayashi Y; Osawa T
Lymphokine Res; 1989; 8(4):393-405. PubMed ID: 2509820
[TBL] [Abstract][Full Text] [Related]
29. Lymphokine-mediated activation of human monocytes: neutralization by monoclonal antibody to interferon-gamma.
Le J; Vilcek J
Cell Immunol; 1984 Apr; 85(1):278-83. PubMed ID: 6424948
[TBL] [Abstract][Full Text] [Related]
30. Identity between human interferon-gamma and "macrophage-activating factor" produced by human T lymphocytes.
Talmadge KW; Gallati H; Sinigaglia F; Walz A; Garotta G
Eur J Immunol; 1986 Dec; 16(12):1471-7. PubMed ID: 3102242
[TBL] [Abstract][Full Text] [Related]
31. A novel human macrophage-activating factor: distinction from interferon-gamma (IFN-gamma) and granulocyte-macrophage colony-stimulating factor (GMCSF).
Jones MP; Gunapala DE; Matutes E; Catovsky D; Coates AR
Cell Immunol; 1988 May; 113(2):361-75. PubMed ID: 2834073
[TBL] [Abstract][Full Text] [Related]
32. Macrophage activation factor from EL-4, a murine T-cell line: antigenic characterization by hamster monoclonal antibodies to murine interferon-gamma.
Meltzer MS; Gilbreath MJ; Crawford RM; Schreiber RD; Nacy CA
Cell Immunol; 1987 Jul; 107(2):340-7. PubMed ID: 3109744
[TBL] [Abstract][Full Text] [Related]
33. Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor.
Svedersky LP; Benton CV; Berger WH; Rinderknecht E; Harkins RN; Palladino MA
J Exp Med; 1984 Mar; 159(3):812-27. PubMed ID: 6421982
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity.
Schreiber RD; Hicks LJ; Celada A; Buchmeier NA; Gray PW
J Immunol; 1985 Mar; 134(3):1609-18. PubMed ID: 2578513
[TBL] [Abstract][Full Text] [Related]
35. IL-10 inhibits the synthesis of migration inhibitory factor and migration inhibitory factor-mediated macrophage activation.
Wu J; Cunha FQ; Liew FY; Weiser WY
J Immunol; 1993 Oct; 151(8):4325-32. PubMed ID: 7691945
[TBL] [Abstract][Full Text] [Related]
36. Coordinate production by a T cell hybridoma of gamma interferon and three other lymphokine activities: multiple activities of a single lymphokine?
Zlotnik A; Roberts WK; Vasil A; Blumenthal E; Larosa F; Leibson HJ; Endres RO; Graham SD; White J; Hill J; Henson P; Klein JR; Bevan MJ; Marrack P; Kappler JW
J Immunol; 1983 Aug; 131(2):794-800. PubMed ID: 6223094
[TBL] [Abstract][Full Text] [Related]
37. Human non-interferon macrophage activating factor: biological and biochemical characterization.
Lee JC; Badger AM; Johnson WJ
Adv Exp Med Biol; 1988; 239():217-21. PubMed ID: 3264453
[TBL] [Abstract][Full Text] [Related]
38. Lymphokine-mediated induction of cytolytic activity in a T cell hybridoma.
Kanagawa O; Chiller JM
J Immunol; 1985 Jan; 134(1):397-403. PubMed ID: 3917280
[TBL] [Abstract][Full Text] [Related]
39. Partial purification and physicochemical properties of human T cell migration inhibitory factor (TIF).
Kowalczyk D; Staykowa M; Litwora E; Pryjma J; Zembala M
J Clin Lab Immunol; 1984 Oct; 15(2):105-10. PubMed ID: 6394762
[TBL] [Abstract][Full Text] [Related]
40. Antigen recognition by effector T cells in antileishmanial defense.
Sypek JP; Panosian CB; Wyler DJ
J Infect Dis; 1985 Nov; 152(5):1057-63. PubMed ID: 2413143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]